FDA Clearance Tracker · P100018-S015
Pipeline Flex Embolization Device
Last checked: Nov 20, 2026Latest source record: Dec 14, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Dec 14, 2018
Approved
Time to decision
534 days
Received Jun 28, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P100018-S015
- Device name
- Pipeline Flex Embolization Device
- Applicant location
- Irvine, CA
- Received
- Jun 28, 2017
- Decided
- Dec 14, 2018
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100018
Device type
- Device type
- Intracranial aneurysm flow diverter (OUT)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Pipeline Flex Embolization Device to expand the indications for use to include use in the internal carotid artery up to the terminus for the endovascular treatment of adults (22 years of age or older) with small and medium wide-necked (neck width >= 4 mm or dome-to-neck ratio < 2) saccular or fusiform intracranial aneurysms arising from a parent vessel with a diameter >= 2.0 mm and <= 5.0 mm.
Source documents
Other decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241388 · Decided Jan 2, 2025 · 232 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K243418 · Decided Dec 2, 2024 · 28 days after receipt
Device type: Apparatus, Suction, Ward Use, Portable, Ac-Powered (JCX) · General & Plastic Surgery
K243080 · Decided Oct 29, 2024 · 29 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.